.jpg)
HAND & WRIST
No difference between one- and two-injection corticosteroid treatments for trigger finger
Hand (N Y). 2014 Sep;9(3):340-5Ninety-seven adult patients suffering from stenosing tenosynovitis, also known as trigger finger, were randomly allocated to treatment using either two staged corticosteroid injections or a single injection. Disabilities of the Arm, Shoulder and Hand (DASH) scores were used to assess effectiveness of treatment; no significant differences in DASH scores were found between one- and two-injection treatments. Diabetic patients (insulin and non-insulin dependent) who experienced treatment failure prior to 1 year after injection were more likely to require surgical intervention than non-diabetic patients.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
